CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Greenlight Biosciences Increases Its RTP Footprint for the Next Generation of Agricultural Goods

Life Sciences Review Life Sciences Review | Tuesday, March 22, 2022
Tweet

The business is developing seven agricultural products with a 6 billion dollar potential market that it hopes to introduce by 2026. GreenLight stated in October that efficient control of fungal diseases utilizing double-stranded RNA got accomplished for the first time.


Fremont, CA: Even before a deadly virus propelled investment into the field to even higher heights, health care and biotech has long been hot business in the startup and technology sectors. However, investors and startup tech businesses say it's not just COVID-19 that's piqued their attention.


From artificial intelligence achievements to more openness about mental health concerns and even growing consumer interest in at-home diagnostics and preventative care, several recent technological innovations and market developments have garnered the majority of investment.


GreenLight Biosciences, a biotechnology business focused on RNA research, design, and production for human, animal, and plant health, expanded its research and development activities in North Carolina's Research Triangle Park (RTP).


See Also : Biotech Startups


The new greenhouse, laboratory, and offices will provide more than 60,000 square feet of space and allow GreenLight's plant health pipeline to expand further, creating additional employment.


"This additional capacity is a critical step that will help us capitalize on our solutions for agriculture to realize a food-secure future," said Mark Singleton, head of plant health at RTP. "The investment will help to keep us at the cutting edge of innovation and continue first-of-a-kind progress like we are currently seeing in our fungal program."


"We expect to have 60 employees on-site by the end of 2022, with our new spaces housing various entomology, fungal, and herbicide projects as well as the functions that support them."


The new greenhouses, where GreenLight will plant a range of crops, will be operational in the first quarter, increasing growth capacity by tenfold. As the firm seeks to deliver creative new tools to farmers to combat pests and diseases such as botrytis and powdery mildew, operations will assist product research and development.


GreenLight anticipates receiving regulatory clearance for its RNA-based product for managing the Colorado potato beetle in 2022, as well as submitting its honeybee health solution to the Environmental Protection Agency.


Weekly Brief

loading
Top 20  BioTech Companies in APAC 2021
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/greenlight-biosciences-increases-its-rtp-footprint-for-the-next-generation-of-agricultural-goods-nwid-710.html